View monthly record counts
| Month | Records |
|---|---|
| 20 |
RELEASE SINGLE EST
BuyerSAUDI ARABIA
Data updated:
Top 3 Import Trade Countries
View all on Tradesparq| # | Country / Region | Records |
|---|---|---|
| 1 | India | 20 |
Top 3 Import HS Codes
View all on Tradesparq| # | HS Code | Description (CN) | Description (EN) | Records |
|---|---|---|---|---|
| 1 | 300490 | 其他混合或非混合产品构成的药品，已配定剂量或制成零售包装 | Other Medicaments consisting of mixed or unmixed products for therapeutic or prophylactic uses, in forms or packings for retail sale | 14 |
| 2 | 300450 | 其他含有维生素或品目29.36所列产品的药品,已配定剂量或制成零售包装 | Other, containing vitamins or other products of heading 29.36 | 4 |
| 3 | 300249 | 毒素、培养微生物（不包括酵母）及类似产品 | Toxins, cultured microorganisms and similar products | 2 |
Top 3 Import Trading Partners
View all on Tradesparq| # | Partner Name | Country / Region | Records |
|---|---|---|---|
| 1 | MYGENIC HEALTHCARE PRIVATE LIMITED | INDIA | 20 |
Latest Import Trade Record
View more records on Tradesparq| Date | Nov 03, 2023 | Bill No. | — | ||
|---|---|---|---|---|---|
| Supplier Information | Company Name | MYGENIC HEALTHCARE PRIVATE LIMITED | Buyer Information | Company Name | RELEASE SINGLE EST |
| Address | — | Address | — | ||
| Registration No. | AATCA8561A | Registration No. | — | ||
| Phone | — | Phone | — | ||
| — | — | ||||
| Product Information | HS Code | 30049049 | HS Description | 其他混合或非混合产品构成的药品，已配定剂量或制成零售包装Other Medicaments consisting of mixed or unmixed products for therapeutic or prophylactic uses, in forms or packings for retail sale | |
| Product Description | Oxoplan 100 gm ( Oxaliplatin) Inj | Brand | — | ||
| Quantity & Price | Amount | 550.00 | Weight | — | |
| Quantity | 55 NOS | TEU | — | ||
| Shipment Information | Origin Country | INDIA | Destination Country | SAUDI ARABIA | |
| Port of Loading | INBOM4 | Destination Port | JEDDAH | ||
| Loading Place | — | Transport Mode | UNKNOWN | ||
| Transaction Mode | — | Carrier | — | ||
| Vessel Name | — | Voyage | — | ||
| Container No. | — | Shipping Country | — | ||